EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations.
Nature. 2012 Dec 6;492(7427):108-12. doi: 10.1038/nature11606. Epub 2012 Oct 10.
Nature. 2012.
PMID: 23051747